Skip to content

Clinical trials

Multiple Myeloma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Japan Clear all

152 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20102
20117
20125
20134
201411
20156
201610
201710
20189
20197
20209
202113
202215
202314
20249
20254
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Active, not recruiting34
Recruiting31
Terminated17
No longer available1
Withdrawn1
Approved for marketing1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC21
Celgene19
AbbVie17
Bristol-Myers Squibb11
Pfizer11
Amgen9
GlaxoSmithKline9
Novartis Pharmaceuticals9
Sanofi9
Janssen Pharmaceutical K.K.8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma152
Recurrence30
Neoplasms15
Leukemia, Myeloid, Acute8
Lymphoma, Non-Hodgkin8
Lymphoma5
Neoplasms, Plasma Cell5
Myelodysplastic Syndromes4
Arrhythmias, Cardiac3
Heart Failure3

Trials

Showing 76 to 100 of 152. Each trial links to its page on Pharma Observatory.

52 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.